PMID- 10200251 OWN - NLM STAT- MEDLINE DCOM- 19990517 LR - 20190501 IS - 0027-8424 (Print) IS - 0027-8424 (Linking) VI - 96 IP - 8 DP - 1999 Apr 13 TI - A mutation in the heterotrimeric stimulatory guanine nucleotide binding protein alpha-subunit with impaired receptor-mediated activation because of elevated GTPase activity. PG - 4268-72 AB - It has been reported that substitution of Arg258, a residue within the GTPase domain of the heterotrimeric guanine nucleotide binding protein (G protein) alpha-subunit (alphas), to alanine (alphas-R258A) results in decreased activation by receptor or aluminum fluoride (AlF4-) and increased basal GDP release. Arg258 interacts with Gln170 in the helical domain, and, presumably, loss of this interaction between the GTPase and helical domain leads to more rapid GDP release, resulting in decreased activation by AlF4- and increased thermolability. In this study, we mutate Gln170 to alanine (alphas-Q170A) and demonstrate that this mutant, like alphas-R258A, has decreased activation by AlF4-, increased thermolability (both reversed in the presence of excess guanine nucleotide), and an increased rate of GDP release. However, unlike alphas-R258A, alphas-Q170A does not have impaired receptor-mediated activation. Therefore, this interdomain interaction is critical to maintain normal guanine nucleotide binding (and hence normal activation by AlF4-) but is not important for receptor-mediated activation. In single turnover GTPase assays, the catalytic rate for GTP hydrolysis of alphas-R258A was 14-fold higher than normal whereas that of alphas-Q170A was unaffected. Examination of the alphas crystal structure suggests that Arg258, through interactions with Glu50, might constrain the position of Arg201, a residue critical for catalyzing the GTPase reaction. This is an example of a mutation in a heterotrimeric G protein that results in an increased intrinsic GTPase activity and provides another mechanism by which G protein mutations can impair signal transduction. FAU - Warner, D R AU - Warner DR AD - Membrane Biochemistry Section, Laboratory of Molecular and Cellular Neurobiology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. dwarner@helix.nih.gov FAU - Weinstein, L S AU - Weinstein LS LA - eng PT - Journal Article PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Aluminum Compounds) RN - 0 (Macromolecular Substances) RN - 0 (Recombinant Proteins) RN - 0RH81L854J (Glutamine) RN - 146-91-8 (Guanosine Diphosphate) RN - 21340-02-3 (tetrafluoroaluminate) RN - 37589-80-3 (Guanosine 5'-O-(3-Thiotriphosphate)) RN - 94ZLA3W45F (Arginine) RN - EC 3.6.1.- (GTP Phosphohydrolases) RN - EC 3.6.5.1 (GTP-Binding Protein alpha Subunits, Gs) RN - EC 4.6.1.1 (Adenylyl Cyclases) RN - L628TT009W (Isoproterenol) RN - Q80VPU408O (Fluorides) SB - IM MH - Adenylyl Cyclases/metabolism MH - Aluminum Compounds/pharmacology MH - Amino Acid Substitution MH - Animals MH - Arginine MH - Cattle MH - Cloning, Molecular MH - Escherichia coli MH - Fibrous Dysplasia, Polyostotic/genetics MH - Fluorides/pharmacology MH - GTP Phosphohydrolases/chemistry/*metabolism MH - GTP-Binding Protein alpha Subunits, Gs/chemistry/genetics/*metabolism MH - Glutamine MH - Guanosine 5'-O-(3-Thiotriphosphate)/metabolism/pharmacology MH - Guanosine Diphosphate/metabolism MH - Humans MH - Isoproterenol/pharmacology MH - Kinetics MH - Macromolecular Substances MH - Mutagenesis, Site-Directed MH - Polymerase Chain Reaction MH - Protein Structure, Secondary MH - Recombinant Proteins/metabolism PMC - PMC16321 EDAT- 1999/04/14 00:00 MHDA- 1999/04/14 00:01 CRDT- 1999/04/14 00:00 PHST- 1999/04/14 00:00 [pubmed] PHST- 1999/04/14 00:01 [medline] PHST- 1999/04/14 00:00 [entrez] AID - 10.1073/pnas.96.8.4268 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4268-72. doi: 10.1073/pnas.96.8.4268.